Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-01-20 @ 4:22 AM
Study NCT ID:
NCT01463059
Status:
COMPLETED
Last Update Posted:
2013-03-25
First Post:
2011-10-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy
Sponsor:
UCB Japan Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RA0083
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None